Aptose Biosciences Inc To Discuss Clinical Update Call Transcript

Jun 10, 2023 / 04:00PM GMT
Operator

Good afternoon. My name is Sherry, and I will be your conference operator today. I would like to welcome everybody to Aptose Biosciences Interim Clinical Update Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to introduce Dan Ferry of Life Science Advisors. Please go ahead.

Daniel Ferry - LifeSci Advisors, LLC - MD & Relationship Manager

Thank you, Sherry. Good afternoon, and welcome to the Aptose Biosciences interim clinical update conference call. Joining me on today's call from EHA 2023 are Dr. William G. Rice, Chairman, President and CEO; and Dr. Rafael Bejar, Senior Vice President and Chief Medical Officer; and Mr. Fletcher Payne, Senior Vice President and Chief Financial Officer. After today's prepared remarks made by Dr. Rice and Dr. Bejar, there will be a question-and-answer session.

Before we proceed, I would like to remind everyone that certain statements made during this call will include forward-looking statements within the meaning of U.S. and Canadian securities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot